Naggie Named Associate Dean for Clinical Research Initiatives and Regulatory Affairs
Susanna Naggie, MD, associate professor of medicine and member of the Duke Clinical Research Institute (DCRI), has been named associate dean for clinical research initiatives and regulatory affairs
Cancer Drugs Speed Airway Repair in Lungs Damaged by Bacterial Infections
Cancer drugs are able to halt life-threatening bacterial lung infections in mouse models by promoting lung repair, researchers at Duke Health have found.
Revised Common Rule 45 CFR 46 Effective on January 21, 2019
As you know, the revised Common Rule 45 CFR 46 will take effect on January 21, 2019. Your studies will be affected in the following ways:
Duke Researchers Partner with Space Agencies to Send Human Models to Space to Test Radiation Risks
Those who remember the crash test dummy commercials for automobiles in the 1980s know that testing new technologies using human models first can help keep actual people safe.
From Innovation to Impact
When four Duke researchers developed an innovative technique for exploring the non-coding genome—the 98 percent of our DNA that does not encode protein sequences, often called the genome’s “dark ma
Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21%
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rat
School of Medicine Taps Utah Cancer Expert as New Chair of Dept. of Medicine
Kathleen Cooney, M.D., a medical oncologist and internationally known physician scientist, has been named chair of the Department of Medicine at Duke University School of Medicine.
Basic Science Day & Lefkowitz Lecture Draw Hundreds
Gene-editing Pioneer Jennifer Doudna Delivers Lefkowitz Lecture